Daan Gene Co., Ltd.
Shenzhen Stock Exchange 002030.SZ
Daan Gene Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 29.20 M
-
Daan Gene Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD 384.33 M, a -7.70% change year over year.
-
Daan Gene Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 416.40 M, a 26.43% change year over year.
-
Daan Gene Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 329.34 M, a 648,331.27% change year over year.
-
Daan Gene Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD -50.81 K, a -100.12% change year over year.
| Date | Free Cash Flow | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
| CEO | Ms. Luo Huang |
| IPO Date | Aug. 9, 2004 |
| Location | China |
| Headquarters | No.19, Xiangshan Road |
| Employees | 1,968 |
| Sector | Health Care |
| Industries | |
Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents and instruments. The company offers fluorescence quantitative PCR products, time resolution series products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and health consultation and management services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. The company was founded in 2001 and is headquartered in Guangzhou, the People's Republic of China.
Past 5 years
USD 2.97
USD 0.79
USD 5.92
USD 2.17
USD 8.16
StockViz Staff
January 15, 2025
Any question? Send us an email